Copy of Presentation to be made to the analyst(s)/investor(s) during "Non-Deal Roadshow" scheduled to be held from August 18, 2026, till August 21, 2026, is attached.
Presentation for Non-Deal Roadshow from Aug 18-21, 2026, at Singapore and Hong Kong
- LTTS highlights global macro themes impacting ER&D including AI and reindustrialization
- Focus on AI-driven growth with $1.24B annualized revenue and 244 AI patents
- Six big bets for next 5 years: Software Defined Mobility, Plant Buildout, Digital Manufacturing, MedTech, Software Platforms, Next-Gen Compute
- Aspires 13-15% revenue CAGR and 16-17% EBIT margin through FY31
- Showcases case studies on autonomous vehicles, digital twins, O&G operations, healthcare solutions
- Emphasizes Engineering Intelligence platform and AI-powered innovation
- Roadshow aims to engage investors on growth strategy and market positioning
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 LTTS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add LTTS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on L&T Technology Services Limited
Important.
The summary above is generated automatically from L&T Technology Services Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.